Schedule 13G ownership disclosure

ACADIA Pharmaceuticals Inc

Common Stock, par value $0.0001 per share · CUSIP: 004225108

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RTW Investments, LP

    Shares: 8,705,501 · Class: 5.2%

  • Roderick Wong, M.D.

    Shares: 8,705,501 · Class: 5.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-020492
Form type
SCHEDULE 13G/A
Filer
ACADIA PHARMACEUTICALS INC
CIK
CIK 1070494
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub